Abstract
Earlier studies and reviews have shown an association between high fasting blood glucose levels (FBG) and increased mortality. Less is known about the association between low FBG and mortality. This study aimed at reviewing the literature on this topic. A search was performed primarily of Medline through PubMed, and secondarily by searching other databases and using the information from articles already found. Altogether 5 articles meeting the quality demands of the search were found, all supporting the association between low FBG and increased all-cause mortality, with multivariate adjusted hazard ratios between 1.2 and 3.2. Another 22 articles not fulfilling the quality criteria were studied, and actually no study contradicted this association. Most studies were focused on the relation between high FBG and mortality, and did not analyze the association between low FBG and mortality specifically, hence explaining the low number of conclusive articles focusing on this. Thus we conclude, that low FBG is associated with increased mortality, but the cause of this association is unclear. We hypothesize, that low FBG could be a marker of low fat-free mass and low nutrition intake. This topic needs further studies.
Keywords: Blood glucose, Mortality, Follow-up studies, Sweden
Current Diabetes Reviews
Title: The Association Between Low Fasting Blood Glucose Value and Mortality
Volume: 3 Issue: 4
Author(s): Per E. Wandell and Holger Theobald
Affiliation:
Keywords: Blood glucose, Mortality, Follow-up studies, Sweden
Abstract: Earlier studies and reviews have shown an association between high fasting blood glucose levels (FBG) and increased mortality. Less is known about the association between low FBG and mortality. This study aimed at reviewing the literature on this topic. A search was performed primarily of Medline through PubMed, and secondarily by searching other databases and using the information from articles already found. Altogether 5 articles meeting the quality demands of the search were found, all supporting the association between low FBG and increased all-cause mortality, with multivariate adjusted hazard ratios between 1.2 and 3.2. Another 22 articles not fulfilling the quality criteria were studied, and actually no study contradicted this association. Most studies were focused on the relation between high FBG and mortality, and did not analyze the association between low FBG and mortality specifically, hence explaining the low number of conclusive articles focusing on this. Thus we conclude, that low FBG is associated with increased mortality, but the cause of this association is unclear. We hypothesize, that low FBG could be a marker of low fat-free mass and low nutrition intake. This topic needs further studies.
Export Options
About this article
Cite this article as:
Wandell E. Per and Theobald Holger, The Association Between Low Fasting Blood Glucose Value and Mortality, Current Diabetes Reviews 2007; 3 (4) . https://dx.doi.org/10.2174/1573399810703040274
DOI https://dx.doi.org/10.2174/1573399810703040274 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial [Hot Topics Anxiety Disorders, Advances in Neurobiology and Neuropharmacology (Executive Guest Editor: Dirk Wedekind)]
Current Pharmaceutical Design Editorial (Thematic Issue: Endocrine Related Cancer: From Stem Cells to New Drug Targets)
Current Medicinal Chemistry Use and Results of Antidepressant Treatment: Patients' Perception
Current Drug Therapy Ceramic Nanoparticles: Fabrication Methods and Applications in Drug Delivery
Current Pharmaceutical Design subject Index To Volume 2
Current Drug Targets - Infectious Disorders Recent Advances in the Development of Nonpeptide Somatostatin Receptor Ligands
Mini-Reviews in Medicinal Chemistry Therapeutic Potentials of A2B Adenosine Receptor Ligands: Current Status and Perspectives
Current Pharmaceutical Design Synthetic and Biological Aspects of Thiadiazoles and their Condensed Derivatives: An Overview
Current Topics in Medicinal Chemistry Cranial Ultrasound - Optimizing Utility in the NICU
Current Pediatric Reviews The Potential for Phospholipids in the Treatment of Airway Inflammation: An Unexplored Solution
Current Molecular Pharmacology Diagnostic Approach to the Patients with Suspected Primary Immunodeficiency
Endocrine, Metabolic & Immune Disorders - Drug Targets Identification of a Cell-Bound Extracellular Protease Overproduced by Sulfolobus solfataricus in Peptide-Rich Media
Protein & Peptide Letters Antithrombotic Treatment in Diabetes Mellitus: A Review of the Literature about Antiplatelet and Anticoagulation Strategies Used for Diabetic Patients in Primary and Secondary Prevention
Current Pharmaceutical Design An Up-to-Date Review on Citrus Flavonoids: Chemistry and Benefits in Health and Diseases
Current Pharmaceutical Design Protrhombotic Effects of Contraceptives
Current Pharmaceutical Design Indication-oriented Ovulation Induction in Assisted Reproduction
Current Women`s Health Reviews Adipose Derived Stem Cells for Musculoskeletal Regeneration: Recent Patents and Future Perspectives
Recent Patents on Regenerative Medicine Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway
Current Cancer Drug Targets Nucleotide Second Messenger Signaling as a Target for the Control of Bacterial Biofilm Formation
Current Topics in Medicinal Chemistry Chitosan: A Versatile Biomedical Polymer
Recent Patents on Biomedical Engineering (Discontinued)